HopeStage
Back to all studies
RecruitingNCT07317206

One dose of ayahuasca or esketamine in adults with PTSD

About this titleRead the official source — NCT07317206
Medication studyAges 18–65Brazil
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
Ribeirão PretoSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: December 20, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
10
Sponsor
University of Sao Paulo
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Brazil
Age range
From 18 Years to 65 Years
Official registry ID
NCT07317206
Official title
Show the full official title

Effects of Single Dose of Ayahuasca or Esketamine on Posttraumatic Stress Disorder: a Randomized, Double-blinded Study

Recruitment & locations

Currently recruiting

Ribeirão Preto

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Sao Paulo, a university.

Does this study involve medication?

Yes. The study involves medication, including Ayahuasca and Esketamine.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies